About ActualMeds
ActualMeds is a company based in East Hartford (United States) founded in 2009 by Anne Marie Biernacki and Patricia Neafsey. ActualMeds has raised $7.76 million across 7 funding rounds from investors including Connecticut Innovations. ActualMeds offers products and services including InConcert Medication Management Platform, Medication Reconciliation, and Chronic Disease Adherence. ActualMeds operates in a competitive market with competitors including AllazoHealth, RxAnte, AdhereHealth, DayaMed and Pilleve, among others.
- Headquarter East Hartford, United States
- Founders Anne Marie Biernacki, Patricia Neafsey
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.76 M (USD)
in 7 rounds
-
Latest Funding Round
$1.25 M (USD), Series A
Sep 27, 2016
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ActualMeds
ActualMeds offers a comprehensive portfolio of products and services, including InConcert Medication Management Platform, Medication Reconciliation, and Chronic Disease Adherence.
Platform for managing patient medications and reducing readmissions through automated outreach.
Service to ensure accurate medication history during care transitions and improve outcomes.
Program for monitoring and optimizing medication for chronic conditions to prevent hospitalizations.
Funding Insights of ActualMeds
ActualMeds has successfully raised a total of $7.76M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.25 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ActualMeds
ActualMeds has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Connecticut Innovations.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Locked | Locked | Locked |
Investor details for ActualMeds
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ActualMeds
Investment portfolio details for ActualMeds
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ActualMeds
Detailed financials for ActualMeds
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Actualmeds Comparisons
Peer comparison for ActualMeds
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ActualMeds
ActualMeds operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AllazoHealth, RxAnte, AdhereHealth, DayaMed and Pilleve, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Analytics services for enhancing medication adherence are offered.
|
|
| Locked | Locked | Locked |
Utilizing predictive analytics to improve the quality of prescription medication use.
|
|
| Locked | Locked | Locked |
Medication adherence platform is provided for healthcare professionals and patients.
|
|
| Locked | Locked | Locked |
Mobile app for medication reminders, tracking, and clinician consultations with insurance coverage.
|
|
| Locked | Locked | Locked |
Platform for monitoring and screening opioid abuse
|
Detailed competitors of ActualMeds
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Actualmeds
Complete news archive for ActualMeds
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ActualMeds
ActualMeds was founded in 2009 and raised its 1st funding round 2 years after it was founded.
ActualMeds is headquartered in East Hartford, United States. It is registered at East Hartford, Connecticut, United States.
ActualMeds is a funded company, having raised a total of $7.76M across 7 funding rounds to date.
ActualMeds provides medication reconciliation on demand at point of care and to automate the process for the care team. It combines medication information from the electronic health record, Health Information Exchanges, prescription claims databases, and a direct provider-conducted structured interview with the patient, it produces the best possible medication history (BPMH). Information displayed from Provider, Payer and Patient is validated and aligned and ready for reconciliation. The company provides Know My Meds, a Web-based solution that is designed to be used by older adults andor their caregivers to keep an up to date record of their medications, including the prescription drugs, OTC, and supplements they are taking.
ActualMeds's top competitors include AllazoHealth, AdhereHealth and RxAnte.
ActualMeds offers InConcert Medication Management Platform, Medication Reconciliation, and Chronic Disease Adherence.
ActualMeds has 1 investor. Key investors include Connecticut Innovations.